Toll-like receptor 9 plays a key role in the autonomic cardiac and baroreflex control of arterial pressure

被引:16
作者
Rodrigues, Fernanda Luciano [1 ]
Silva, Luiz Eduardo V. [2 ]
Hott, Sara Cristina [1 ]
Bomfim, Gisele F. [3 ]
Aguiar da Silva, Carlos Alberto [2 ]
Fazan, Rubens, Jr. [2 ]
Resstel, Leonardo B. M. [1 ]
Tostes, Rita C. [1 ]
Carneiro, Fernando S. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Med School, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med School, Dept Physiol, BR-14049900 Ribeirao Preto, SP, Brazil
[3] Univ Fed Mato Grosso, Inst Hlth Sci, Sinop, Mato Grosso, Brazil
基金
巴西圣保罗研究基金会;
关键词
TLR9; parasympathetic nervous system; spontaneous baroreflex; HEART-RATE-VARIABILITY; SYMPATHETIC-NERVOUS-SYSTEM; II-INDUCED HYPERTENSION; BLOOD-PRESSURE; SUBDIAPHRAGMATIC VAGOTOMY; CONTEXTUAL FEAR; IMMUNE-SYSTEM; MITOCHONDRIAL-DNA; NEURAL REGULATION; MESSENGER-RNA;
D O I
10.1152/ajpregu.00150.2014
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The crosstalk between the immune and the autonomic nervous system may impact the cardiovascular function. Toll-like receptors are components of the innate immune system and play developmental and physiological roles. Toll-like receptor 9 (TLR9) is involved in the pathogenesis of cardiovascular diseases, such as hypertension and heart failure. Since such diseases are commonly accompanied by autonomic imbalance and lower baroreflex sensitivity, we hypothesized that TLR9 modulates cardiac autonomic and baroreflex control of arterial pressure (AP). Toll-like receptor 9 knockout (TLR9 KO) and wild-type (WT) mice were implanted with catheters into carotid artery and jugular vein and allowed to recover for 3 days. After basal recording of AP, mice received methyl-atropine or propranolol. AP and pulse interval (PI) variability were evaluated in the time and frequency domain (spectral analysis), as well as by multiscale entropy. Spontaneous baroreflex was studied by sequence technique. Behavioral and cardiovascular responses to fear-conditioning stress were also evaluated. AP was similar between groups, but TLR9 KO mice exhibited lower basal heart rate (HR). AP variability was not different, but PI variability was increased in TLR9 KO mice. The total entropy was higher in TLR9 KO mice. Moreover, baroreflex function was found higher in TLR9 KO mice. Atropine-induced tachycardia was increased in TLR9 KO mice, whereas the propranolol-induced bradycardia was similar to WT mice. TLR9 KO mice exhibit increased behavioral and decreased tachycardia responses to fear-conditioning stress. In conclusion, our findings suggest that TLR9 may negatively modulate cardiac vagal tone and baroreflex in mice.
引用
收藏
页码:R714 / R723
页数:10
相关论文
共 50 条
  • [31] Mitochondrial DNA and Toll-Like Receptor-9 Are Associated With Mortality in Critically Ill Patients
    Krychtiuk, Konstantin A.
    Ruhittel, Sarah
    Hohensinner, Philipp J.
    Koller, Lorenz
    Kaun, Christoph
    Lenz, Max
    Bauer, Benedikt
    Wutzlhofer, Lisa
    Draxler, Dominik F.
    Maurer, Gerald
    Huber, Kurt
    Wojta, Johann
    Heinz, Gottfried
    Niessner, Alexander
    Speidl, Walter S.
    CRITICAL CARE MEDICINE, 2015, 43 (12) : 2633 - 2641
  • [32] PM2.5 increases mouse blood pressure by activating toll-like receptor 3
    Zhang, Jinna
    Chen, Rucheng
    Zhang, Guoqing
    Wang, Yixuan
    Peng, Jing
    Li, Ran
    Zhang, Lu
    Sun, Qinghua
    Liu, Cuiqing
    Hu, Renji
    Gu, Weijia
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2022, 234
  • [33] MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedside
    Wittig, Burghardt
    Schmidt, Manuel
    Scheithauer, Werner
    Schmoll, Hans-Joachim
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 31 - 44
  • [34] A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury
    David, Brian T.
    Ratnayake, Ayomi
    Amarante, Matthew A.
    Reddy, Naresh Parvath
    Dong, Wei
    Sampath, Sujitha
    Heary, Robert F.
    Elkabes, Stella
    NEUROBIOLOGY OF DISEASE, 2013, 54 : 194 - 205
  • [35] Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?
    Holtick, Udo
    Klein-Gonzalez, Nela
    von Bergwelt-Baildon, Michael S.
    IMMUNOTHERAPY, 2011, 3 (03) : 301 - 304
  • [36] Toll-Like Receptor 4 Gene Polymorphisms and Susceptibility to Schizophrenia: A Case-Control Study
    Mostafa, Maged
    Elwasify, Mohamed
    Fathy, Aya Ahmed
    Abdelsalam, Maha
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (07) : 2009 - 2024
  • [37] Intermittent hypoxia and arterial blood pressure control in humans: role of the peripheral vasculature and carotid baroreflex
    Tremblay, Joshua C.
    Boulet, Lindsey M.
    Tymko, Michael M.
    Foster, Glen E.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 311 (03): : H699 - H706
  • [38] Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
    Karime, Christian
    Wang, Jing
    Woodhead, Gregory
    Mody, Kabir
    Hennemeyer, Charles T.
    Borad, Mitesh J.
    Mahadevan, Daruka
    Chandana, Sreenivasa R.
    Babiker, Hani
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 1 - 13
  • [39] Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
    Dhondup, Yangchen
    Sjaastad, Ivar
    Scott, Helge
    Sandanger, Oystein
    Zhang, Lili
    Haugstad, Solveig Bjaerum
    Aronsen, Jan Magnus
    Ranheim, Trine
    Holmen, Sigve Dhondup
    Alfsnes, Katrine
    Ahmed, Muhammad Shakil
    Attramadal, Havard
    Gullestad, Lars
    Aukrust, Pal
    Christensen, Geir
    Yndestad, Arne
    Vinge, Leif Erik
    PLOS ONE, 2015, 10 (10):
  • [40] Macrophage Mineralocorticoid Receptor Signaling Plays a Key Role in Aldosterone-Independent Cardiac Fibrosis
    Bienvenu, Laura A.
    Morgan, James
    Rickard, Amanda J.
    Tesch, Greg H.
    Cranston, Greg A.
    Fletcher, Elizabeth K.
    Delbridge, Lea M. D.
    Young, Morag J.
    ENDOCRINOLOGY, 2012, 153 (07) : 3416 - 3425